NDC 70436-035

lincomycin

Lincomycin

lincomycin is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Slate Run Pharmaceuticals, Llc. The primary component is Lincomycin.

Product ID70436-035_f154ee8a-a848-4620-e053-2a95a90a0702
NDC70436-035
Product TypeHuman Prescription Drug
Proprietary Namelincomycin
Generic NameLincomycin
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2022-12-30
Marketing CategoryANDA /
Application NumberANDA216662
Labeler NameSlate Run Pharmaceuticals, LLC
Substance NameLINCOMYCIN
Active Ingredient Strength300 mg/mL
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 70436-035-80

1 VIAL in 1 CARTON (70436-035-80) > 3000 mL in 1 VIAL
Marketing Start Date2022-12-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "lincomycin" or generic name "Lincomycin"

NDCBrand NameGeneric Name
0404-9901LINCOMYCINlincomycin hydrochloride
39822-0350Lincomycinlincomycin hydrochloride
39822-0353Lincomycinlincomycin hydrochloride
42571-374LincomycinLincomycin
50090-4533Lincomycinlincomycin hydrochloride
52584-353LINCOMYCINlincomycin hydrochloride
70436-034lincomycinlincomycin
70436-035lincomycinlincomycin
70625-113Lincomycinlincomycin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.